This suggests that the indication and reason for taking GLP-1s likely play a role in effectiveness, as those focused on only glycemic control may not see any change in weight loss, and vice versa
The reduction of MACE with WEGOVY injection was not impacted by age, sex, race, ethnicity, BMI at baseline, or level of renal function impairment
La hiperglucemia crnica condiciona un microambiente entrico alterado, con incremento del estrs oxidativo, formacin de productos finales de la glucosilacin avanzada, inflamacin y reduccin de neurotransmisores y hormonas locales, afectando la vasculatura entrica y la celularidad del msculo liso19
Lets get to the point
Moreover, liraglutide trials in patients with HFrEF provided no clinical benefit, underscoring that the efficacy of incretin receptor agonism does not uniformly extend across heart-failure phenotypes and that remodelling mechanisms may differ by disease context [47]
10.1046/j.1365-313x.1998.00343.x Plant J